Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Immunol. 2011 Oct 31;187(11):5921–5930. doi: 10.4049/jimmunol.1100746

Fig. 6.

Fig. 6

Correlation between IL-10 Elispots with and without glyphosine in the presence of B:9–23 peptide. Mean IL-10 Elispots from (A) DQ8 Individuals with type 1 diabetes (n=14) and (B) non-diabetic DQ8 controls (n=8). There is a statistically significant correlation between the insulin B:9–23 spot number and spots in the presence of peptide and glyphosine for individuals with type 1 diabetes (p=0.002, r2=0.56). There is no correlation with the DQ8 controls (p=0.30, r2=0.17). T1D = type 1 diabetes.